Lantern Pharma (LTRN) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.56
-0.5
-0.45
-0.39

Details

Expected EPS
-0.56
Actual EPS
-0.42
Surprise EPS
0.14
Surprise Percent
+25%

Description

Lantern Pharma (LTRN) has reported earnings of -0.42 per share for Q4 2024.

0 Comments

Share your thoughts